Our research focuses on developing and translating novel PET methods for the study of neurodevelopment and neuropsychiatric illness. This involves using PET methodologies to investigate neurochemical changes in the brain and studying novel radioligands to characterize neurotransmitter-protein interactions and how they are influenced by development, genes, environment and drugs. These imaging methods are being applied to investigate the etiologies and mechanisms in diseases such as Down syndrome, affective disorders, schizophrenia, Alzheimer’s disease and Tourette syndrome.
December 2016 to April 2017
This project led by: Bradley Christian, PhD